Enterprise Value
60.82M
Cash
9.146M
Avg Qtr Burn
-1.796M
Short % of Float
11.07%
Insider Ownership
18.98%
Institutional Own.
8.79%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Ibezapolstat Details Clostridioides difficile infection | Phase 3 Initiation |